e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled volatile organic compounds for better asthma control: could it be a future noninvasive adherence test?
Florence N. Schleich, Delphine Zanella, Jean-François Focant
Source:
Eur Respir J, 55 (2) 1902112; 10.1183/13993003.02112-2019
Journal Issue:
February
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Florence N. Schleich, Delphine Zanella, Jean-François Focant. Exhaled volatile organic compounds for better asthma control: could it be a future noninvasive adherence test?. Eur Respir J, 55 (2) 1902112; 10.1183/13993003.02112-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Respiratory sequelae of preterm birth across the life span
Time to breathe: Challenges in the successful management of asthma during conception, pregnancy and delivery
Related content which might interest you:
Exhaled volatile organic compounds as markers for medication use in asthma
Source: Eur Respir J, 55 (2) 1900544; 10.1183/13993003.00544-2019
Year: 2020
Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009
Limited clinical value of exhaled volatile organic compound measurements in childhood asthma
Source: ERJ Open Res, 4 (4) 00026-2018; 10.1183/23120541.00026-2018
Year: 2018
Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Value of exhaled volatile organic compounds in monitoring airway disease
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013
Exhaled carbon monoxide as a marker of tobacco exposure: is it possible to use the same parameters in COPD patients?
Source: Eur Respir J 2006; 28: Suppl. 50, 389s
Year: 2006
Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function
Source: International Congress 2015 – The next generation of lung function tests
Year: 2015
Design of accurate COPD classification model based on volatile organic compounds from exhaled air
Source: Annual Congress 2008 - New challenges and maintained quality: lung function for the future
Year: 2008
Is the analysis of torbamycin in exhaled breath condensate a diagnostic tool to monitor pulmonary drug deposition?
Source: Eur Respir J 2004; 24: Suppl. 48, 386s
Year: 2004
Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study
Source: Eur Respir J 2013; 42: 98-106
Year: 2013
Volatile organic compounds in COPD: Is hexanal an inflammation biomarker?
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate
Source: Eur Respir J 2006; 28: Suppl. 50, 747s
Year: 2006
Does the measurement of exhaled nitric oxide before and after specific inhalation challenges improve the diagnosis of occupational asthma?
Source: International Congress 2019 – Occupational lung diseases: from diagnostic techniques to classical and novel causes
Year: 2019
Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
The assessment of exhaled nitric oxide fraction in monitoring asthma control: How to raise the clinical relevance?
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010
Multiple detectable exhaled volatile organic compounds (vocs) may serve as potential inflammatory biomarkers in COPD
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
Volatile organic compounds (VOC) in exhaled breath of patients with COPD
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept